Progressive genetic aberrations detected by comparative genomic hybridisation in squamous cell cervical cancer

被引:166
作者
Allen, DG [1 ]
White, DJ
Hutchins, AM
Scurry, JP
Tabrizi, SN
Garland, SM
Armes, JE
机构
[1] Mercy Hosp Women, Dept Gynecol Oncol, Melbourne, Vic 3002, Australia
[2] Mercy Hosp Women, Dept Pathol, Melbourne, Vic 3002, Australia
[3] Victorian Breast Canc Res Consortium, Mol Pathol Lab, Melbourne, Vic 3002, Australia
[4] Peter MacCallum Canc Inst, Dept Pathol, Melbourne, Vic 3002, Australia
[5] Royal Hosp Women, Dept Pathol, Carlton, Vic 3053, Australia
关键词
comparative genomic hybridization; cervix cancer; lymph node metastasis; human papillomavirus;
D O I
10.1054/bjoc.2000.1509
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Genetic changes orchestrated by human papillomaviruses are the most important known factors in carcinogenesis of the uterine cervix. However, it is clear that additional genetic events are necessary for tumour progression. We have used comparative genomic hybridization to document non-random chromosomal gains and losses within a subset of 37 cervical carcinomas matched for clinical stage Ib, but with different lymph node status. There were significantly more chromosomal changes in the primary tumours when the lymph nodes were positive for metastases. The most frequent copy number alterations were loss of 3p, 11q, 6q and 10q and gain of 3q. The smallest areas of loss and gain on chromosome 3 were 3p14-22 and 3q24-26. The study identifies progressive DNA copy number changes associated with early-stage invasive cervical cancers with and without lymph node metastases, a factor of potential prognostic and therapeutic value. (C) 2000 Cancer Research Campaign.
引用
收藏
页码:1659 / 1663
页数:5
相关论文
共 31 条
  • [1] Aubele M, 1998, CANCER CYTOPATHOL, V84, P375, DOI 10.1002/(SICI)1097-0142(19981225)84:6<375::AID-CNCR10>3.0.CO
  • [2] 2-1
  • [3] GENITAL HUMAN PAPILLOMAVIRUS INFECTION IN FEMALE UNIVERSITY-STUDENTS AS DETERMINED BY A PCR-BASED METHOD
    BAUER, HM
    TING, Y
    GREER, CE
    CHAMBERS, JC
    TASHIRO, CJ
    CHIMERA, J
    REINGOLD, A
    MANOS, MM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (04): : 472 - 477
  • [4] Dellas A, 1999, CANCER RES, V59, P3475
  • [5] DURST M, 1987, ONCOGENE, V1, P251
  • [6] LOSS OF HETEROZYGOSITY IN CERVICAL-CARCINOMA - SUBCHROMOSOMAL LOCALIZATION OF A PUTATIVE TUMOR-SUPPRESSOR GENE TO CHROMOSOME 11Q22-Q24
    HAMPTON, GM
    PENNY, LA
    BAERGEN, RN
    LARSON, A
    BREWER, C
    LIAO, S
    BUSBYEARLE, RMC
    WILLIAMS, AWR
    STEEL, CM
    BIRD, CC
    STANBRIDGE, EJ
    EVANS, GA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (15) : 6953 - 6957
  • [7] Heselmeyer K, 1997, GENE CHROMOSOME CANC, V19, P233, DOI 10.1002/(SICI)1098-2264(199708)19:4<233::AID-GCC5>3.3.CO
  • [8] 2-K
  • [9] Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix
    Heselmeyer, K
    Schrock, E
    duManoir, S
    Blegen, H
    Shah, K
    Steinbeck, R
    Auer, G
    Ried, T
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (01) : 479 - 484
  • [10] ISOLA JJ, 1995, AM J PATHOL, V147, P905